Nandini Acharya

Nandini Acharya studies how the immune system, particularly T cells, behaves in cancer and in the brain tumor glioblastoma, with a focus on how hormone signals (like glucocorticoids), cytokines (such as IL-27, IL-23, IL-16), and inhibitory immune checkpoints (like Tim-3) shape immune cell function and dysfunction in tumors. The goal of this work is to identify ways to improve cancer immunotherapy by understanding and reprogramming these immune regulatory circuits. This research combines immunology, cancer biology, and molecular biology techniques.

Publication output has been variable with some gaps (e.g., 2021, 2023) but has increased notably in the most recent years (2024-2026), suggesting growing recent activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026